Shannon Mohollen, PA
Physician Assistant · Wilmington, DENPI 1659962207
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$552
- Scilex Pharmaceuticals Inc.$422
- Valinor Pharma, LLC$385
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$336
- Pfizer$334
- Lilly USA, LLC$184
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,508100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 41 | $552 |
| Scilex Pharmaceuticals Inc. | 21 | $422 |
| Valinor Pharma, LLC | 20 | $385 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $336 |
| Pfizer | 18 | $334 |
| Lilly USA, LLC | 8 | $184 |
| IBSA Pharma Inc. | 8 | $175 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $169 |
| Redhill Biopharma Inc. | 4 | $105 |
| Abbott | 2 | $73 |
| AstraZeneca | 3 | $70 |
| Boston Scientific | 3 | $60 |
| Nevro Corp. | 2 | $59 |
| QOL Medical, LLC | 3 | $54 |
| Amneal Pharmaceuticals LLC | 3 | $54 |
| Biodelivery Sciences International, Inc. | 3 | $43 |
| Novo Nordisk | 2 | $37 |
| Tersera Therapeutics LLC | 2 | $36 |
| Vertex | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| Ardelyx, Inc. | 1 | $25 |
| Neos Therapeutics, LP | 1 | $25 |
| Almatica Pharma LLC | 1 | $25 |
| Electronic Waveform Lab, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $24 |
| Protega Pharmaceutials Inc | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,508 in reported general payments places this provider in the 90th percentile of 527 physician assistant providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 52 | $45,844 |
| OxycontinOxycodone Hcl | 58 | $42,656 |
| NucyntaTapentadol Hcl | 17 | $39,062 |
| Xtampza ErOxycodone Myristate | 60 | $36,427 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 566 | $15,772 |
| Nucynta ErTapentadol Hcl | 11 | $14,904 |
| Oxycodone Hcl | 539 | $10,539 |
| MovantikNaloxegol Oxalate | 24 | $9,500 |
| Buprenorphine | 34 | $8,908 |
| Lidocaine | 64 | $6,120 |
| Tramadol Hcl ErTramadol Hcl | 82 | $4,998 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 178 | $4,433 |
| Fentanyl | 38 | $4,256 |
| Morphine Sulfate ErMorphine Sulfate | 160 | $3,798 |
| Gabapentin | 220 | $2,612 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Xtampza Er, Nucynta Er | $552 | $136,237140 claims |
| Redhill Biopharma Inc.Movantik | $105 | $9,50024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 527 physician assistant providers in Delaware.
Other physician assistant in Wilmington
- Jason SaulWilmington$9K
- Brooke EnderleWilmington$7K
- Matthew StumpWilmington$5K
- Christopher HoverWilmington$5K
- Julie SimsWilmington$5K
- Joan TaddeiWilmington$4K
- Gabriel PelaezWilmington$4K
- Caitlin McCarryWilmington$4K
- Samantha DelfeldWilmington$4K
- Victoria SandlerWilmington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.